PLK1 and familial pancreatic carcinoma: Additionally, PLK1 mRNA levels in high PTEN-expressing group have been significantly up-regulated compared with those in low PTEN-expressing group in GSE78229 and GSE62452 data sets, which had an adverse prognosis of pancreatic cancer patients to elevated PTEN expression (Figure 6c).